16867-04-2 Usage
Description
2,3-Dihydroxypyridine (DHP) is an organic compound characterized by the presence of two hydroxy groups at positions 2 and 3 on the pyridine ring. It appears as a khaki to grey or brown crystalline powder. DHP is known for its versatile chemical properties, which make it a valuable component in various applications across different industries.
Uses
Used in Chemical Synthesis:
2,3-Dihydroxypyridine is used as a key intermediate in the synthesis of various compounds. Its ability to form chelates with metal ions makes it a popular choice for creating macromolecular chelators, which are essential in various chemical processes.
2,3-Dihydroxypyridine is used as a chelating agent for [enhancing the stability and selectivity of metal ion complexes] in the synthesis of new macromolecular chelators by loading DHP on cellulose via linkers -NH-CH2-CH2-NH-SO2-C6H4-N=Nand -SO2-C6H4-N=N-.
Used in Amberlite XAD-2 Synthesis:
In the field of polymer chemistry, 2,3-Dihydroxypyridine is used as a component in the synthesis of DHP loaded amberlite XAD-2 via azo coupler. This application takes advantage of DHP's ability to form stable complexes with metal ions, which can be beneficial in various industrial processes.
2,3-Dihydroxypyridine is used as a component in [creating a metal ion complex with enhanced stability and selectivity] for the synthesis of DHP loaded amberlite XAD-2 via azo coupler.
Check Digit Verification of cas no
The CAS Registry Mumber 16867-04-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,8,6 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 16867-04:
(7*1)+(6*6)+(5*8)+(4*6)+(3*7)+(2*0)+(1*4)=132
132 % 10 = 2
So 16867-04-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H5NO2/c7-4-2-1-3-6-5(4)8/h1-3,7H,(H,6,8)
16867-04-2Relevant articles and documents
-
Moehrle,Weber
, p. 3779,3783 (1970)
-
DERMATOLOGICAL COMPOSITIONS AND METHODS
-
, (2008/06/13)
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.
Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway
-
, (2008/06/13)
Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.